CohBar, Inc. (CWBR) Q4 2021 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Tuhura Biosciences, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.029 -- 00:00:04.052 Good afternoon. My name is Kyle and I will be your conference operator today. 00:00:04.052 -- 00:00:08.836 At this time, I'd like to welcome everyone to CoBAR's fourth quarter and full year 2021 00:00:08.836 -- 00:00:13.179 financial results conference call. All lines have been placed on mute to eliminate background 00:00:13.179 -- 00:00:17.382 noise. A question and answer session will follow the formal presentation. 00:00:17.382 -- 00:00:21.605 If anyone should require operator assistance during the conference, please press star 00:00:21.605 -- 00:00:26.385 zero on your telephone keypad. Please note this conference is being recorded. 00:00:26.385 -- 00:00:30.107 Now, I'd like to turn the call over to Jordan Tarazi, Director of Investor Relations 00:00:30.107 -- 00:00:32.347 at COBAR. 00:00:32.469 -- 00:00:36.371 Thank you, Kyle, and thank you, everyone, for joining COBAR's fourth quarter and full 00:00:36.371 -- 00:00:37.832 year 2021 00:00:37.832 -- 00:00:42.374 financial results conference call. Joining me on today's call is Joe Surrett, COBAR's 00:00:42.374 -- 00:00:47.097 Chief Executive Officer, and Jeff Buno, COBAR's Chief Financial Officer. 00:00:47.097 -- 00:00:49.779 I would also like to take this opportunity to welcome Dr. 00:00:49.779 -- 00:00:54.841 Nick Vlahakis, COBAR's newly appointed Chief Medical Officer, who will also be providing 00:00:54.841 -- 00:00:59.921 remarks today. Following our collective remarks, we will conclude with Q&A, at which 00:00:59.921 -- 00:01:04.444 time Dr. Kent Greinstaff, SVP of Research, will also join us. 00:01:04.444 -- 00:01:08.787 COBRA's financial results press release was issued earlier today and may be downloaded 00:01:08.787 -- 00:01:11.789 from our website at cobra.com. 00:01:11...